Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma

Jumpei Teramachi; Masahiro Hiasa; Asuka Oda; Takeshi Harada; Shingen Nakamura; Ryota Amachi; Hirofumi Tenshin; Masami Iwasa; Shiro Fujii; Kumiko Kagawa; Hirokazu Miki; Kiyoe Kurahashi; Sumiko Yoshida; Itsuro Endo; Tatsuji Haneji; Toshio Matsumoto; Masahiro Abe

doi:10.1111/bjh.14388

Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma

Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Takeshi Harada, Shingen Nakamura, Ryota Amachi, Hirofumi Tenshin, Masami Iwasa, Shiro Fujii, Kumiko Kagawa, Hirokazu Miki, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto, Masahiro Abe

研究成果 › 査読

13 被引用数 (Scopus)

本文言語	English
ページ（範囲）	581-585
ページ数	5
ジャーナル	British Journal of Haematology
巻	180
号	4
DOI	https://doi.org/10.1111/bjh.14388
出版ステータス	Published - 2月 1 2018
外部発表	はい

ASJC Scopus subject areas

血液学

文献へのアクセス

10.1111/bjh.14388

他のファイルとリンク

引用スタイル

Teramachi, J., Hiasa, M., Oda, A., Harada, T., Nakamura, S., Amachi, R., Tenshin, H., Iwasa, M., Fujii, S., Kagawa, K., Miki, H., Kurahashi, K., Yoshida, S., Endo, I., Haneji, T., Matsumoto, T., & Abe, M. (2018). Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma. British Journal of Haematology, 180(4), 581-585. https://doi.org/10.1111/bjh.14388

Teramachi, J, Hiasa, M, Oda, A, Harada, T, Nakamura, S, Amachi, R, Tenshin, H, Iwasa, M, Fujii, S, Kagawa, K, Miki, H, Kurahashi, K, Yoshida, S, Endo, I, Haneji, T, Matsumoto, T & Abe, M 2018, 'Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma', British Journal of Haematology, vol. 180, no. 4, pp. 581-585. https://doi.org/10.1111/bjh.14388

@article{4e6e65466f80415cb2eea597b90e7cb9,

title = "Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma",

keywords = "Pim-2, bone destruction, myeloma, osteoclastogenesis, receptor activator of NF-κB ligand",

author = "Jumpei Teramachi and Masahiro Hiasa and Asuka Oda and Takeshi Harada and Shingen Nakamura and Ryota Amachi and Hirofumi Tenshin and Masami Iwasa and Shiro Fujii and Kumiko Kagawa and Hirokazu Miki and Kiyoe Kurahashi and Sumiko Yoshida and Itsuro Endo and Tatsuji Haneji and Toshio Matsumoto and Masahiro Abe",

note = "Funding Information: This work was supported in part by Grant-in-Aid for Young Scientists (B) to J.T., R.A., S.N., and H.M., Grants-in-aid for Scientific Research (C) to M.A., and a Grant-in-aid for Cancer Research (17-16) to M.A. from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",

year = "2018",

month = feb,

day = "1",

doi = "10.1111/bjh.14388",

language = "English",

volume = "180",

pages = "581--585",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma

AU - Teramachi, Jumpei

AU - Hiasa, Masahiro

AU - Oda, Asuka

AU - Harada, Takeshi

AU - Nakamura, Shingen

AU - Amachi, Ryota

AU - Tenshin, Hirofumi

AU - Iwasa, Masami

AU - Fujii, Shiro

AU - Kagawa, Kumiko

AU - Miki, Hirokazu

AU - Kurahashi, Kiyoe

AU - Yoshida, Sumiko

AU - Endo, Itsuro

AU - Haneji, Tatsuji

AU - Matsumoto, Toshio

AU - Abe, Masahiro

N1 - Funding Information: This work was supported in part by Grant-in-Aid for Young Scientists (B) to J.T., R.A., S.N., and H.M., Grants-in-aid for Scientific Research (C) to M.A., and a Grant-in-aid for Cancer Research (17-16) to M.A. from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

PY - 2018/2/1

Y1 - 2018/2/1

KW - Pim-2

KW - bone destruction

KW - myeloma

KW - osteoclastogenesis

KW - receptor activator of NF-κB ligand

UR - http://www.scopus.com/inward/record.url?scp=84991687106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991687106&partnerID=8YFLogxK

U2 - 10.1111/bjh.14388

DO - 10.1111/bjh.14388

M3 - Letter

C2 - 27748523

AN - SCOPUS:84991687106

SN - 0007-1048

VL - 180

SP - 581

EP - 585

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 4

ER -